Actinium Pharmaceuticals, Inc.

ATNM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 16, 2026
3 Oct 16, 2026
ARS Oct 15, 2026 ARS
DEF 14A Oct 15, 2026 PROXY STATEMENT
8-K Oct 15, 2026 CURRENT REPORT
S-8 Oct 9, 2026 REGISTRATION STATEMENT
3 Sep 10, 2026
3 Sep 10, 2026
4 Sep 4, 2026
4 Sep 4, 2026
4 Sep 4, 2026
4 Sep 4, 2026
4 Sep 4, 2026
4 Sep 4, 2026
8-K Aug 14, 2026 CURRENT REPORT
10-Q Aug 7, 2026 QUARTERLY REPORT
8-K Jun 18, 2026 CURRENT REPORT
8-K May 29, 2026 CURRENT REPORT
10-Q May 8, 2026 QUARTERLY REPORT
10-K Mar 30, 2026 ANNUAL REPORT
8-K/A Mar 26, 2026 AMENDMENT NO.1 TO FORM 8-K
8-K Feb 13, 2026 CURRENT REPORT
8-K Nov 26, 2025 CURRENT REPORT
10-Q Nov 14, 2025 QUARTERLY REPORT
ARS Nov 5, 2025 ARS
← Newer Page 1 of 21 · 511 filings Older →